These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 10216831)

  • 1. Correlation between the predicted and the observed biological activity of the symmetric and nonsymmetric cyclic urea derivatives used as HIV-1 protease inhibitors. A 3D-QSAR-CoMFA method for new antiviral drug design.
    Avram S; Svab I; Bologa C; Flonta ML
    J Cell Mol Med; 2003; 7(3):287-96. PubMed ID: 14594553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the refinement of merohedrally twinned P6
    Lockbaum GJ; Leidner F; Royer WE; Kurt Yilmaz N; Schiffer CA
    Acta Crystallogr D Struct Biol; 2020 Mar; 76(Pt 3):302-310. PubMed ID: 32133994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STEREOCONTROLLED SYNTHESIS OF HIV-l PROTEASE INHIBITORS WITH C
    Ghosh AK; McKee SP; Thompson WJ
    Tetrahedron Lett; 1991 Oct; 32(41):5729-5732. PubMed ID: 30310242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-peptidic HIV protease inhibitors.
    Chrusciel RA; Strohbach JW
    Curr Top Med Chem; 2004; 4(10):1097-114. PubMed ID: 15193141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of HIV protease inhibitors].
    Yang QG; He XC; Bai DL
    Yao Xue Xue Bao; 2005 May; 40(5):389-94. PubMed ID: 16220778
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of azacyclic urea A-98881 as HIV-1 protease inhibitor with cage dimeric N-benzyl 4-(4-methoxyphenyl)-1,4-dihydropyridine as representative of a novel class of HIV-1 protease inhibitors: a molecular modeling study.
    Hilgeroth A; Fleischer R; Wiese M; Heinemann FW
    J Comput Aided Mol Des; 1999 May; 13(3):233-42. PubMed ID: 10216831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis.
    Debnath AK
    J Med Chem; 1999 Jan; 42(2):249-59. PubMed ID: 9925730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of the first N-alkyl cage dimeric 4-aryl-1,4-dihydropyridines as novel nonpeptidic HIV-1 protease inhibitors.
    Hilgeroth A; Wiese M; Billich A
    J Med Chem; 1999 Nov; 42(22):4729-32. PubMed ID: 10579836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1,4-dihydropyridines as competitive HIV-1 protease inhibitors.
    Hilgeroth A; Billich A; Lilie H
    Eur J Med Chem; 2001 Apr; 36(4):367-74. PubMed ID: 11461762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular recognition of cyclic urea HIV-1 protease inhibitors.
    Ala PJ; DeLoskey RJ; Huston EE; Jadhav PK; Lam PY; Eyermann CJ; Hodge CN; Schadt MC; Lewandowski FA; Weber PC; McCabe DD; Duke JL; Chang CH
    J Biol Chem; 1998 May; 273(20):12325-31. PubMed ID: 9575185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricyclic ureas: a new class of HIV-1 protease inhibitors.
    Han W; Pelletier JC; Hodge CN
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3615-20. PubMed ID: 9934481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV-1 protease inhibitors in review].
    Hilgeroth A
    Pharm Unserer Zeit; 1998 Jan; 27(1):22-5. PubMed ID: 9562781
    [No Abstract]   [Full Text] [Related]  

  • 13. Retroviral proteases: structure, function and inhibition from a non-anticipated viral enzyme to the target of a most promising HIV therapy.
    von der Helm K
    Biol Chem; 1996 Dec; 377(12):765-74. PubMed ID: 8997487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450.
    Hodge CN; Aldrich PE; Bacheler LT; Chang CH; Eyermann CJ; Garber S; Grubb M; Jackson DA; Jadhav PK; Korant B; Lam PY; Maurin MB; Meek JL; Otto MJ; Rayner MM; Reid C; Sharpe TR; Shum L; Winslow DL; Erickson-Viitanen S
    Chem Biol; 1996 Apr; 3(4):301-14. PubMed ID: 8807858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease.
    Sham HL; Zhao C; Stewart KD; Betebenner DA; Lin S; Park CH; Kong XP; Rosenbrook W; Herrin T; Madigan D; Vasavanonda S; Lyons N; Molla A; Saldivar A; Marsh KC; McDonald E; Wideburg NE; Denissen JF; Robins T; Kempf DJ; Plattner JJ; Norbeck DW
    J Med Chem; 1996 Jan; 39(2):392-7. PubMed ID: 8558507
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.